21 unknown. 21 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 21 | Unknown 21 |
| Phase 2 | 1 | Unknown 1 |
Follow Neuralgia: new trials by email Literature Review of Neuralgia trials Research Report on Neuralgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Adezunap, Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Traumatic or Post-operative Peripheral Neuropathy Adezunap (AP707), Placebo - Pain, Pain Syndrome | Phase 3 | Unknown | Apurano Pharmaceuticals GmbH | 558 | 2023-11-02 | 2024-01-31 |
| Intrathecal Ziconotide Antalgic Efficacy for Severe Refractory Neuropathic zicotinide followed by placebo, Placebo followed by zicotinide - Severe Refractory Neuropathic Pain, Spinal Cord Lesions | Phase 3 | Unknown | Hospices Civils de Lyon | 44 | 2019-06-20 | 2019-05-08 |
| Fibrin for Chronic Multi-level Discogenic Low Back Pain Fibrin sealant - Low Back Pain, Disc Disease | Phase 2 / Phase 3 | Unknown | Pauza, Kevin, MD | 400 | 2018-06-11 | 2020-11-09 |
| Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway Ketamine 10 MG/ML, Placebos, Midazolam 1 MG/ML - Neuralgia, Chronic Pain | Phase 3 | Unknown | Redar | 48 | 2018-02-16 | 2018-05-02 |
| Pregabalin Treatment and Prevention Post-herpetic Neuralgia Pregabalin, Gabapentin - Herpetic Neuralgia | Phase 3 | Unknown | Second Affiliated Hospital of Guangzhou Medical University | 342 | 2017-10-01 | 2017-06-14 |
| Treatment of Neuropathic Pain in Leprosy Amitriptyline, Placebo oral capsule, Tramadol - Pain, Neuropathic, Leprosy | Phase 3 | Unknown | University of Sao Paulo | 102 | 2017-03-01 | 2022-02-23 |
| Virtual Reality for Chronic Neuropathic Pain Immersive Virtual Reality (Gear VR) - Spinal Cord Injuries, Neuropathic Pain | Phase 3 | Unknown | Kathleen Friel | 40 | 2016-07-01 | 2019-07-10 |
| Nerveblocks for Persistent Pain After Breast Cancer Surgery Bupivacaine, NaCl - Pain, Neuropathic Pain | Phase 3 | Unknown | Kenneth Geving Andersen | 48 | 2016-07-01 | 2015-10-27 |
| Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia Placebo, Pregabalin SR tablet 165mg/day, Pregabalin SR tablet 330mg/day - Postherpetic Neuralgia | Phase 3 | Unknown | Jiangsu HengRui Medicine Co., Ltd. | 280 | 2015-03-01 | 2016-08-16 |
| Efficacy and Safety of KW21052 Compared to Lyrica in the Diabetic Patients With Neuropathic Pain KW21052, Lyrica, Lyrica (low dose) - Diabetic Neuropathy | Phase 3 | Unknown | KunWha Pharmaceutical Co., Ltd. | 394 | 2013-08-01 | 2013-05-29 |
| Effect of Opioids in Neuropathic Pain in Postherpetic Patients Remifentanil - Neuralgia, Postherpetic | Phase 3 | Unknown | Medical University of Vienna | 30 | 2010-08-01 | 2010-04-12 |
| To Evaluate the Efficacy and Tolerability of the Use of Vitatonus Dexa Compared to Dexamethasone in Patients With Neuralgia of Various Origins Dexamethasone - Neuralgia | Phase 3 | Unknown | Bunker Industria Farmaceutica Ltda. | 104 | 2009-10-01 | 2009-07-24 |
| Surgical Treatment Of Complex Regional Pain Syndrome Type II (CRPS II) SUBCUTANEOUS VENOUS SYMPATHECTOMY (RSVS) - CRPS Type II | Phase 3 | Unknown | Medical University of Vienna | 20 | 2009-01-01 | 2011-07-12 |
| Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer amitriptyline, pregabalin - Cancer, Neuralgia | Phase 3 | Unknown | Radboud University Medical Center | 130 | 2008-09-01 | 2009-02-05 |
| Diabetic Neuropathy Topical Treatment ketamine, vehicle gel, ketamine + clonidine - Diabetic Neuropathy, Pain | Phase 3 | Unknown | Irmandade da Santa Casa de Misericordia de Sao Paulo | 200 | 2008-04-01 | 2008-04-18 |
| Efficacy Study of Nabilone in the Treatment of Diabetic Peripheral Neuropathic Pain Nabilone, flexible dosing - Diabetic Neuropathies | Phase 3 | Unknown | University of Calgary | 60 | 2008-01-01 | 2009-12-18 |
| The Effects of the Magnetic Molecular Energizer (MME) on Diabetic Peripheral Neuropathy MME procedure - Diabetic Neuropathies, Pain | Phase 3 | Unknown | Advanced Magnetic Research Institute International | 100 | 2005-07-01 | 2007-07-10 |
Showing 20 of 21. Sign in to see all of them.
Pain (8) · Agnosia (5) · Chronic Pain (5) · Diabetic Neuropathies (4) · Marijuana Abuse (4) · Somatoform Disorders (4) · Neuralgia, Postherpetic (3) · Brain Injuries, Traumatic (2) · Multiple Sclerosis (2) · Pain, Postoperative (2) · Paraplegia (2) · Peripheral Nerve Injuries (2) · Peripheral Nervous System Diseases (2) · Phantom Limb (2)
Nervous System Diseases (21) · Neurologic Manifestations (21) · Neuromuscular Diseases (21) · Pathological Conditions, Signs and Symptoms (21) · Signs and Symptoms (21) · Peripheral Nervous System Diseases (19) · Pain (13) · Neurobehavioral Manifestations (5) · Pathologic Processes (5) · Perceptual Disorders (5) · Trauma, Nervous System (5) · Wounds and Injuries (5) · Chemically-Induced Disorders (4) · Diabetes Complications (4)
Pregabalin (3) · Amitriptyline (2) · Ketamine (2) · Bupivacaine (1) · Clonidine (1) · Dexamethasone (1) · Fibrin Tissue Adhesive (1) · Gabapentin (1) · Meperidine (1) · Midazolam (1) · Remifentanil (1) · Tramadol (1) · nabilone (1)
Apurano Pharmaceuticals GmbH (4) · Medical University of Vienna (2) · Advanced Magnetic Research Institute International (1) · Austin Health (1) · Bunker Industria Farmaceutica Ltda. (1) · Hospices Civils de Lyon (1) · Irmandade da Santa Casa de Misericordia de Sao Paulo (1) · Jiangsu HengRui Medicine Co., Ltd. (1) · Kathleen Friel (1) · Kenneth Geving Andersen (1) · KunWha Pharmaceutical Co., Ltd. (1) · Pauza, Kevin, MD (1) · Radboud University Medical Center (1) · Redar (1) · Second Affiliated Hospital of Guangzhou Medical University (1)
Germany (4) · Brazil (3) · United States (3) · Austria (2) · China (2) · Australia (1) · Canada (1) · France (1) · Netherlands (1) · South Korea (1)
Cory Toth, MD (1) · Daniel Andrade, PhD (1) · Dean A Cowie, MBBS, FANZCA (1) · Didier Bouhassira, Md, PhD (1) · Judymara L Gozzani, Investigator (1) · Kathleen Friel, PhD (1) · Kenneth G Andersen, MD, PhD (1) · Kevin Pauza, MD (1) · Kris Vissers, MD PhD FIPP (1) · Kwang-Kuk Kim, M.D., Ph.D. (1) · Li Wan, Ph.D.,M.D. (1) · Lu Qianjin, M.D. (1) · Nelun Wijayasinghe, MD (1) · Rosa Hasan (1)
PMID 16466610, PMID 35587172, PMID 39428602, PMID 42152617
2017 (1)